Platelet aggregation and antithrombin III levels in diabetic children.

Platelet aggregation in diabetic retinopathy.

Letter: Natural oestrogens and antithrombin-III levels.

Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function.

Effects of dietary palm oil on serum lipid peroxidation, antithrombin III, plasma cyclic AMP, and platelet aggregation.

[Measurement of spontaneous platelet aggregation. Platelet aggregation test III (author's transl)].

Antithrombin III and heparin.

Antithrombin III and heparin.

Antithrombin III and arterial disease.

Effect of diabetic duration on hemorheological properties and platelet aggregation in streptozotocin-induced diabetic rats.

Familial antithrombin III deficiency.

Antithrombin III immunoprecipitation pattern.

Safety of virus inactivated antithrombin III concentrate antithrombin III immuno (AT III).

Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease: a study of stroke before 55.

The antithrombin III gene polymorphism in Japan: examination for haplotypes relevant to disordered antithrombin III biosynthesis.

Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule.

Effect of cancer chemotherapy drugs on platelet aggregation in children.

Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery.

Linkage study of antithrombin III.

Antithrombin-III transfusion in disseminated intravascular coagulation.

Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses.

[Benefits and risks of antithrombin III concentrates].

The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin.

Antithrombin III in kidney-related diseases.

Antithrombin III immunoelectrophoretic pattern in DIC.

Suggest Documents

Platelet aggregation in diabetic retinopathy.

Letter: Natural oestrogens and antithrombin-III levels.

Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function.

Effects of dietary palm oil on serum lipid peroxidation, antithrombin III, plasma cyclic AMP, and platelet aggregation.

[Measurement of spontaneous platelet aggregation. Platelet aggregation test III (author's transl)].

Antithrombin III and heparin.

Antithrombin III and heparin.

Antithrombin III and arterial disease.

Effect of diabetic duration on hemorheological properties and platelet aggregation in streptozotocin-induced diabetic rats.

Familial antithrombin III deficiency.

Antithrombin III immunoprecipitation pattern.

Safety of virus inactivated antithrombin III concentrate antithrombin III immuno (AT III).

Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease: a study of stroke before 55.

The antithrombin III gene polymorphism in Japan: examination for haplotypes relevant to disordered antithrombin III biosynthesis.

Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule.

Effect of cancer chemotherapy drugs on platelet aggregation in children.

Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery.

Linkage study of antithrombin III.

Antithrombin-III transfusion in disseminated intravascular coagulation.

Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses.

[Benefits and risks of antithrombin III concentrates].

The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin.

Antithrombin III in kidney-related diseases.

Antithrombin III immunoelectrophoretic pattern in DIC.

Platelet aggregation and antithrombin III levels in diabetic children.

Recommend Documents

Follow Us